IP Library Granted Patent US 9,169,482
Granted Patent B2
US 9,169,482 · App. 13/697,665 · Granted Oct 27, 2015

Method for synthesizing cDNA

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,169,482
App. No.
13/697,665
Granted
Oct 27, 2015
Kind
B2
Abstract

A method for synthesizing cDNA characterized by preparing a reaction solution that does not allow an endodeoxyribonuclease to show its activity, without thermal deactivation of the endodeoxyribonuclease or removal of the endodeoxyribonuclease, and carrying out a reverse transcription reaction, wherein the reaction solution contains a treated sample and a reverse transcriptase, the treated sample being formed by treating a sample comprising RNA and DNA with the endodeoxyribonuclease to degrade DNA in the sample. The method and the kit for synthesizing cDNA of the present invention are widely useful in genetic engineering fields.

Claims (16)

1. A method for synthesizing cDNA which comprises the following steps (a) to (c):

(a) obtaining a composition comprising a sample comprising RNA and DNA, and an endodeoxyribonuclease;

(b) treating the composition obtained in step (a) under conditions sufficient to degrade the DNA; and

(c) adding an additive comprising at least dithiothreitol and ammonium ion, and a reverse transcriptase to the composition treated in step (b) to prepare a reaction solution wherein activity of the endodeoxyribonuclease is inhibited without heat denaturation at 60° C. or higher, and carrying out a reverse transcription reaction with the reverse transcriptase to synthesize cDNA,

wherein the concentration of dithiothreitol in the reaction solution ranges from 11 mM to 30 mM, and

wherein the concentration of ammonium ion in the reaction solution ranges from 20 mM to 60 mM.

2. The method according to claim 1 , wherein the endodeoxyribonuclease is deoxyribonuclease I.

3. The method according to claim 1 , wherein the reverse transcriptase is a reverse transcriptase derived from Moloney murine leukemia virus.

4. The method according to claim 1 , further comprising the step of carrying out a gene amplification reaction with the synthesized cDNA as a template.

5. The method according to claim 2 , further comprising the step of carrying out a gene amplification reaction with the synthesized cDNA as a template.

6. The method according to claim 3 , further comprising the step of carrying out a gene amplification reaction with the synthesized cDNA as a template.

7. The method according to claim 1 , wherein the activity of the endodeoxyribonuclease is inhibited by at least 71%.

8. The method according to claim 1 , wherein the concentration of dithiothreitol in the reaction solution ranges from 11.25 to 20 mM.

9. The method according to claim 8 , wherein the additive further comprises a potassium ion.

10. The method according to claim 9 , wherein the additive further comprises magnesium ion in a concentration of 2 mM.

11. The method according to claim 1 , wherein the concentration of ammonium ion in the reaction solution ranges from 28 mM to 56 mM.

Assignments (2)
CHANGE OF ADDRESS Recorded Jun 24, 2016
From: TAKARA BIO INC.
To: TAKARA BIO INC.
Reel/Frame 039152/0834 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2012
From: NAKABAYASHI, YUKO; UEMORI, TAKASHI; MUKAI, HIROYUKI; ASADA, KIYOZO
To: TAKARA BIO INC.
Reel/Frame 029297/0562 →